eyeknow. what's your price target in mid 2011. eyeknow what i reckon .12+ and that still make it only a $60m market cap. re-rate will push past that oppies strike price of .07 much quicker than people think.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025